A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to ...

Plans with high deductibles — the amount that patients must pay for most medical care before insurance starts pitching in — ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

Individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) have increased incidence rates of sudden cardiac death (SCD) compared with the general population.

I know that diabetes can take a real toll on your body, but I didn't know that it includes your eyes. How are they affected ...

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...

Objectives We hypothesise that women with type 2 diabetes and hypertension are less likely than comparable men to receive renin–angiotensin system (RAS)-inhibiting antihypertensive treatment, ...

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy‘s cash ...

Orforglipron as an adjunct to lifestyle modification was better than placebo for weight and cardiometabolic measures of health.

Inhaled Technosphere insulin (TI) vs subcutaneous RAA did not meet the noninferiority margin for glycated HbA1c in youth with diabetes.

The 2026 update to the ADA’s Standards of Care in Diabetes introduces new guidance on a wide range of topics, including the ...